Litigation Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (D. Del. 2023)
✉ Email this page to a colleague
United Therapeutics Corporation v. Liquidia Technologies, Inc. (D. Del. 2023)
Docket | ⤷ Try a Trial | Date Filed | 2023-09-05 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | Sherry R. Fallon |
Patents | 10,036,054; 6,002,008; 6,011,007; 6,011,068; 6,222,025; 6,552,004; 7,041,017; 7,157,017; 7,417,070; 7,544,713; 8,008,003; 8,013,002; 8,013,112; 8,017,150; 8,022,036; 8,022,064; 8,044,014; 8,067,025; 8,497,393; 9,000,002; 9,018,017; 9,024,034; 9,339,507; 9,358,240; 9,593,066; 9,604,901 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in United Therapeutics Corporation v. Liquidia Technologies, Inc.
Biologic Drugs cited in United Therapeutics Corporation v. Liquidia Technologies, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (D. Del. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-04-19 | 71 | Redacted Document | 10:36:54 18 A. Aaron B. Waxman. …later-listed patent, U.S. Patent No. 10,716,793 (“the ’793 patent”), but because that patent was later- … Decision • U.S. Patent numbers: Patent 9,604,901, Patents 9,593,066, Patent 10,716,793 • Under Hatch-Waxman…]. US Patent No. 5,153,222 US Patent No. 6,765,117 US Patent No. 6,521,212 US Patent No. 6,756,…both the '327 patent 8 patent? 9 and the '793 patent describe the use of | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |